18
Views
16
CrossRef citations to date
0
Altmetric
Research Article

Prevalence of HIV Protease Mutations on Failure of Nelfinavir-Containing HAART: A Retrospective Analysis of Four Clinical Studies and Two Observational Cohorts

, , , , &
Pages 316-323 | Published online: 02 Feb 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Perez George, MacArthur Rodger D.Walmsley Sharon, Baxter John A.Mullin Chris & Neaton James D.. (2004) A Randomized Clinical Trial Comparing Nelfinavir and Ritonavir in Patients with Advanced HIV Disease (CPCRA 042/CTN 102). HIV Clinical Trials 5:1, pages 7-18.
Read now

Articles from other publishers (15)

Rabia Can Sarinoglu, Uluhan Sili, Ufuk Hasdemir, Burak Aksu, Guner Soyletir & Volkan Korten. (2022) Diversity of HIV-1 Subtypes and Transmitted Drug-resistance Mutations Among Minority HIV-1 Variants in a Turkish Cohort. Current HIV Research 20:1, pages 54-62.
Crossref
Mina Cintho Ozahata, Ester Cerdeira Sabino, Ricardo Sobhie Diaz, Roberto M Cesar-JrJr & João Eduardo Ferreira. (2015) Data-intensive analysis of HIV mutations. BMC Bioinformatics 16:1.
Crossref
Vishal Prashar, Subhash C. Bihani, Jean-Luc Ferrer & Madhusoodan V. Hosur. (2015) Structural Basis of Why Nelfinavir-Resistant D30N Mutant of HIV-1 Protease Remains Susceptible to Saquinavir. Chemical Biology & Drug Design 86:3, pages 302-308.
Crossref
Patricia MuneratoMaria Cecilia SucupiraMárcia P.R. OliverosLuiz Mario JaniniDenise Ferreira de SouzaAnderson Alvarenga PereiraLilian Amaral InocencioRicardo Sobhie Diaz. (2010) HIV Type 1 Antiretroviral Resistance Mutations in Subtypes B, C, and F in the City of São Paulo, Brazil. AIDS Research and Human Retroviruses 26:3, pages 265-273.
Crossref
Mark A WainbergJorge L Martinez-CajasBluma G Brenner. (2007) Strategies for the optimal sequencing of antiretroviral drugs toward overcoming and preventing drug resistance. Future HIV Therapy 1:3, pages 291-313.
Crossref
Marie-Laure Chaix, Fran??ois Rouet, Kouakou Alain Kouakoussui, Rockiath Laguide, Patricia Fassinou, Crepin Montcho, St??phane Blanche, Christine Rouzioux & Philippe Msellati. (2005) Genotypic Human Immunodeficiency Virus Type 1 Drug Resistance in Highly Active Antiretroviral Therapy-Treated Children in Abidjan, C??te d??Ivoire. The Pediatric Infectious Disease Journal 24:12, pages 1072-1076.
Crossref
Veronica Svedhem, A. Lindkvist, T. Bergroth, Lidman Knut & A. Sönnerborg. (2005) Diverse pattern of protease inhibitor resistance mutations in HIV‐1 infected patients failing nelfinavir. Journal of Medical Virology 76:4, pages 447-451.
Crossref
Perry N. HalkitisMichael T. Shrem, David D. Zade & Leo Wilton. (2016) The Physical, Emotional and Interpersonal Impact of HAART: Exploring the Realities of HIV Seropositive Individuals on Combination Therapy. Journal of Health Psychology 10:3, pages 345-358.
Crossref
Caroline M Perry, James E Frampton, Paul L McCormack, M Asif A Siddiqui & Risto S Cvetkovi??. (2005) Nelfinavir. Drugs 65:15, pages 2209-2244.
Crossref
Elizabeth S. Machado, John S. Lambert, Adriana O. Afonso, Silvia M. Cunha, Ricardo H. Oliveira, Amilcar Tanuri, Anne M. Sill, Antonio J. L. Costa & Marcelo A. Soares. (2004) ALTERNATIVE, AGE- AND VIRAL LOAD-RELATED ROUTES OF NELFINAVIR RESISTANCE IN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1-INFECTED CHILDREN RECEIVING HIGHLY ACTIVE ANTIRETROVIRAL THERAPY. The Pediatric Infectious Disease Journal 23:11, pages 1057-1059.
Crossref
Zehava Grossman, Ellen E. Paxinos, Diana Averbuch, Shlomo Maayan, Neil T. Parkin, Dan Engelhard, Margalit Lorber, Valery Istomin, Yael Shaked, Ella Mendelson, Daniela Ram, Chris J. Petropoulos & Jonathan M. Schapiro. (2004) Mutation D30N Is Not Preferentially Selected by Human Immunodeficiency Virus Type 1 Subtype C in the Development of Resistance to Nelfinavir. Antimicrobial Agents and Chemotherapy 48:6, pages 2159-2165.
Crossref
Dan Turner, Jonathan M Schapiro, Bluma G Brenner & Mark A Wainberg. (2003) The Influence of Protease Inhibitor Resistance Profiles on Selection of HIV Therapy in Treatment-Naive Patients. Antiviral Therapy 9:3, pages 301-314.
Crossref
. (2004) Comparison of Regimens as Initial Therapy for HIV. New England Journal of Medicine 350:10, pages 1053-1054.
Crossref
E. Fumero & D. Podzamczer. (2003) New patterns of HIV-1 resistance during HAART. Clinical Microbiology and Infection 9:11, pages 1077-1084.
Crossref
Richard Ogden. 2003. Viral Infections and Treatment. Viral Infections and Treatment 523 553 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.